Inhibition of NRTKs in the PTK2B-Src-ABL2-cortactin cascade, in particular of ABL2, effectively inhibits the invadopodia-mediated invasiveness and metastasis of human breast cancer cells in a mouse tumor model [493]. This evidence concerns the gene SRC and breast cancer.